Found: 30
Select item for more details and to access through your institution.
Risk assessment of thromboembolic events in hospitalized cancer patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97659-9
- By:
- Publication type:
- Article
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-22543-z
- By:
- Publication type:
- Article
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231204857
- By:
- Publication type:
- Article
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: a 10-year, retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920970081
- By:
- Publication type:
- Article
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12225-6
- By:
- Publication type:
- Article
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 4, p. 182, doi. 10.1159/000497211
- By:
- Publication type:
- Article
Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 430, doi. 10.3390/cancers14020430
- By:
- Publication type:
- Article
Early Changes of the Standardized Uptake Values (SUV max) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3314, doi. 10.3390/cancers12113314
- By:
- Publication type:
- Article
Oral Capecitabine-Vinorelbine Is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 617, doi. 10.3390/cancers12030617
- By:
- Publication type:
- Article
Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 67, doi. 10.3390/cancers12010067
- By:
- Publication type:
- Article
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2019, v. 11, n. 4, p. 484, doi. 10.3390/cancers11040484
- By:
- Publication type:
- Article
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 14, p. 2733, doi. 10.1002/1878-0261.13256
- By:
- Publication type:
- Article
Lymphotoxin beta‐activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma.
- Published in:
- Liver International, 2024, v. 44, n. 11, p. 2950, doi. 10.1111/liv.16069
- By:
- Publication type:
- Article
Bcl‐x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2855, doi. 10.1111/liv.15392
- By:
- Publication type:
- Article
NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 1, p. e2350756, doi. 10.1001/jamanetworkopen.2023.50756
- By:
- Publication type:
- Article
Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 8, p. 10156, doi. 10.1002/cam4.5719
- By:
- Publication type:
- Article
Platinum sensitivity in patients with IDH1/2 mutated vs wild‐type intrahepatic cholangiocarcinoma: A propensity score‐based study.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 8, p. 1310, doi. 10.1002/ijc.34182
- By:
- Publication type:
- Article
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan.
- Published in:
- Clinical Colorectal Cancer, 2020, v. 19, n. 3, p. 156, doi. 10.1016/j.clcc.2020.05.004
- By:
- Publication type:
- Article
Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01510-9
- By:
- Publication type:
- Article
Clinical implications for pro-GRP in small cell lung cancer. A single center experience.
- Published in:
- International Journal of Biological Markers, 2018, v. 33, n. 1, p. 55, doi. 10.5301/ijbm.5000305
- By:
- Publication type:
- Article
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 3, p. 359, doi. 10.1007/s11523-024-01060-1
- By:
- Publication type:
- Article
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 1, p. 139, doi. 10.1007/s11523-022-00933-7
- By:
- Publication type:
- Article
Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Trifluridine/Tipiracil (TAS‐102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1178, doi. 10.1634/theoncologist.2017-0573
- By:
- Publication type:
- Article
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.925551
- By:
- Publication type:
- Article